@article{Sullivan_F-2022_84050,
title = {Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection},
author = {Sullivan, F. and Tello, A. and Rauchhaus, P. and Hernandez Santiago, V. and Daly, F.},
month = {may},
year = {2022},
abstract = {Background: Patients with more severe forms of SARS-CoV-2 exhibit activation of immunological cascades. Participants (current or ex-smokers with at least 20 years pack history) in a trial (Early Diagnosis of Lung Cancer, Scotland [ECLS]) of autoantibody detection to predict lung cancer risk had seven autoantibodies measured 5 years before the pandemic. This study compared the response to Covid infection in study participants who tested positive and negative to antibodies to tumour-associated antigens: p53, NY-ESO-1, CAGE, GBU4-5, HuD, MAGE A4 and SOX2.},
pages = {24-27},
volume = {11},
issue = {1},
journal = {Journal of Circulating Biomarkers},
publisher = {AboutScience},
url = {https://doi.org/10.33393/jcb.2022.2337},
}
